Table 2 Clinical characteristics, etiology and outcome of 35 adult patients with acute cerebellitis, including our case
From: Acute cerebellitis in adults: a case report and review of the literature
Characteristics | N/N (%) |
|---|---|
Median age (range) | 36 (18–73) |
Male sex | 13/35 (37) |
Medical history | |
 None | 6/19 (32) |
 Malignancy | 3/19 (16) |
 Hepatitis C infection | 2/19 (11) |
Symptoms | |
 Headache | 23/26 (88) |
 Fever | 12/17 (71) |
 Nystagmus | 13/32 (41) |
 Vertigo | 11/32 (34) |
 Nausea/vomiting | 14/16 (88) |
 Dysarthria | 26/34 (76) |
 Ataxia | 29/31 (94) |
 Altered consciousness | 10/35 (29) |
 Neck stiffness | 4/11 (36) |
Etiology | |
 Unknown | 12/35 (34) |
 Medication-induced | 4/35 (11) |
 Paraneoplastic | 3/35 (9) |
 Para-infectious | 2/35 (6) |
 Epstein–Barr virus in cerebrospinal fluid | 2/35 (6) |
 Influenza in cerebrospinal fluid | 2/35 (6) |
 Mycoplasma pneumoniae in cerebrospinal fluid | 2/35 (6) |
 Herpes simplex in cerebrospinal fluid | 2/35 (6) |
 Other | 2/35 (6) |
 Scrub typhus | 1/35 (3) |
 Coxsackie virus in cerebrospinal fluid | 1/35 (3) |
 Salmonella in cerebrospinal fluid | 1/35 (3) |
 Cryptococcus neoformans in cerebrospinal fluid | 1/35 (3) |
Brain magnetic resonance imaging findings | |
 T1: cortical hypointensity | 7/13 (54) |
 T2/FLAIR: cortical hyperintensity | 23/29 (79) |
 DWI/ADC: restriction | 8/10 (80) |
 T1 C+ (gadolinium): cortical and leptomeningeal enhancement | 18/23 (78) |
 Hydrocephalus | 9/35 (26) |
Cerebrospinal fluid findings | |
 Median leukocyte count (/mL) (range) | 104 (0–797) |
 Median protein (g/L) (range) | 0.72 (0.08–2.00) |
Treatment | |
 Steroids | 16/35 (46) |
 Antiviral medication | 12/35 (34) |
 Antibiotics | 9/35 (26) |
 Surgery | 7/35 (20) |
Outcome | |
 Full recovery | 16/30 (53) |
 Sequelae | 14/30 (47) |
 Death | 0/35 (0) |
Follow-up brain magnetic resonance imaging findings | 21/35 (60) |
 Normal | 6/21 (29) |
 Improved, but with persistent abnormalities | 11/21 (52) |
 Cerebellar atrophy | 4/21 (19) |